Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions
The document discusses updates to the WHO's Thirteenth General Programme of Work Results Framework. It outlines four strategic objectives: create an enabling environment, increase financial investments, promote data sharing, and ensure access to research benefits. It describes the balanced scorecard approach to assess performance across six dimensions. Country case studies will measure achievements and lessons learned in selected countries. Consultations on the results framework will continue through 2019 regional committee meetings to foster ownership among member states.
Similar to Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions
Similar to Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions (20)
Call Girls Bangalore Saanvi 7001305949 Independent Escort Service Bangalore
Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions
1. Tehran,
Islamic Republic of Iran
14 –17 October 2019
1
Coordination of work of the World
Health Assembly, Executive Board
and the regional committees
Agenda items 4(c) through 4(f)
2. Tehran,
Islamic Republic of Iran
14 –17 October 2019
Agenda item 4(c)
Dr Rana Hajjeh,
Director, Programme Management
Development of a global
strategy for tuberculosis
research and innovation
3. 3
The Seventy-first World Health Assembly in resolution
WHA71.3 requested the WHO Director-General to:
develop a global strategy for tuberculosis research and
innovation
make further progress in enhancing cooperation and
coordination in respect of TB research and development
draw on relevant existing research networks and global
initiatives where possible.
4. Overall vision:
From political commitment to action
4
Four
strategic
objectives
Create an enabling
environment
Increase financial
investments
Promote and improve
approaches to data sharing
Ensure equitable access to
the benefits of research
and innovation
Goal: A framework to facilitate TB research and
innovation contributing to the goals and targets of the
End TB Strategy
5. Structure of the document
5
1. Introduction and scope
Overall landscape of the TB epidemic and the research
environment
2. The challenge and the way forward
Key needs, knowledge gaps, primary challenges and strategic
goals in TB research (basic research, product development
and implementation/operations research)
4. Recommendations
For countries, global partners, civil society and international
agencies
3.Strategic objectives
Key for breaking the barriers (leveraging existing strategies,
platforms and opportunities)
5. Implementation and monitoring progress
6. Strategy roadmap
6
Preparation
2018
Develop strategy
20182019
Monitor implementation
2020
✔ Request from World
Health Assembly (WHA)
✔ Approval from STAG
✔ Internal (WHO)
consultation
to develop a research
strategy
✔ October 2018 – Consultation with high
TB burden countries
✔ October 2018 – Consultation with
research stakeholders
✔ January 2019 – Global TB Research
Task Force
✔ 10 April – First UN missions briefing
✔ 21 March–8 May 2019 – Open
consultation (web)
✔ 11–13 June 2019 – STAG
✔ 1 July 2019 – Second UN missions
briefing
✔ 29 August2019 – Third UN missions
briefing
August–October 2019 – WHO
Regional Committee meetings
January 2020 – Executive Board
Accountability and advocacy
71st WHA
May 2018
73rd WHA
May 2020
7. Tehran,
Islamic Republic of Iran
14 –17 October 2019
7
Summary of the draft global strategy
on digital health
Agenda item 4(d)
Dr Rana Hajjeh,
Director, Programme
Management
8. Vision
To improve health for
everyone, everywhere by
accelerating the development
and adoption of appropriate
digital health solutions
towards achieving
the health-related SDGs
8
9. Strategic objectives
9
1
Promote global collaboration and advance the transfer of
knowledge on digital health
2
Advance implementation of national digital health
strategies
3
Strengthen governance for digital health at global and
national levels
4
Advocate for people-centred health systems enabled by
digital health
10. 10
OBJECTIVES OUTCOMES IMPACT
Promote collaboration
and transfer of
knowledge on digital
health
Global alignment to
address opportunities
and challenges
Sustainable digital
health ecosystem
Advance
implementation of
national digital health
strategies
Strategic vision and
integrated action at the
national level
Cost-effective health
systems and services
Strengthen governance
for digital health
Actions and investments
based on informed
decisions
Accelerated
digitalization of the
health and well-being
sector
People-centred health
systems enabled by
digital health
People empowered to
make healthy and health-
enabling choices
Healthier population
11. Enabling environment
11
SHORT
TERM
MEDIUM
TERM
LONG TERM
ROLE OF
MEMBER
STATES
ROLE OF
WHO
ROLE OF
PARTNERS
TIME FOR ACTION JOINT RESPONSIBILITY
GLOBAL
STRATEGY
ON
DIGITAL
HEALTH
Country and
user adoption of
action plan
Incubation
acceleration and
scale up
Prioritize
investment on
data and digital
health
Standards
and policy
Solution
selection and
purchasing
12. Global strategy timeline
12
Resolution
WHA71.7 on
digital health
Public
stakeholders
consultation
Member
States
consultation
WHO
regional
committees
WHO
Executive
Board
World Health
Assembly
• Global
Strategy
version 1.0
• Global
Strategy
version 2.0
• Global Strategy
version 3.0
• Action plan version
1.0
• Global Strategy
final draft
• Action plan final
draft
May 2018 MarchJune 2019 JuneJuly 2019
• Global Strategy
version 3.0
• Action plan 2.0
AugustOctober 2019 January 2020 May 2020
14. Tehran,
Islamic Republic of Iran
14 –17 October 2019
14
Agenda item 4(e)
Dr Rana Hajjeh,
Director, Programme
Management
Draft global strategy to
accelerate cervical cancer
elimination
15. 144th Executive Board (EB144.2)
15
To develop, in consultation with
Member States and other relevant
stakeholders,
a global strategy to accelerate cervical
cancer elimination, with clear goals
and targets for the period 2020–2030
16. Draft global strategy towards the elimination
of
cervical cancer as a public health problem
Cervical
cancer
elimination
a priority for
GPW 13
Health system
strengthening
for social
protection and
UHC
Global health
sector
strategies on
HIV, hepatitis
and STIs
WHA70.12 on
cancer
prevention
and control
Global
Strategy for
Women’s,
Children’s and
Adolescents’
Health
16
17. Regional situation
17
Third most common female cancer in
Region
Top 5 most common cancers in 11 countries
Incidence is projected to almost double by
2040
National cancer registries and access to
quality data to inform policy direction
remains low
Human papillomavirus (HPV) vaccination
available in 2 countries only
9 countries report availability of national
cervical cancer screening programmes,
most opportunistic and low participation
High mortality to incidence ratio, indicating
poor early detection and/or poor access to
treatment
Country % of
cervical
cancer to all
cancers
Rank
(/30)
Afghanistan 6.7 2
Bahrain 3.3 8
Djibouti 11.7 2
Egypt 1.5 14
Gaza Strip and West
Bank
1.6 15
Iran, Islamic Republic of 1.8 15
Iraq 1.7 13
Jordan 1.8 11
Kuwait 2.9 8
Lebanon 2.3 10
Libya 10.1 3
Morocco 12.3 2
Oman 5.8 4
Pakistan 6.0 3
Qatar 3.9 5
Saudi Arabia 2.6 8
Somalia 15.5 2
Sudan 7.0 2
Syrian Arab Republic 2.0 12
Tunisia 3.9 3
United Arab Emirates 4.1 5
Yemen 2.3 12Source: IARC Globocan, 2018
18. Draft global strategy towards the elimination
of cervical cancer as a public health problem
18
2030 CONTROL TARGETS
90%
of girls fully
vaccinated
with HPV
vaccine by 15
years of age
70%
of women
screened
with an HPV
test at 35 and
45 years of
age
90%
of women
screened
positive
receive
treatment for
precancerou
s lesion or
invasive
cancer
SDG 2030: Target 3.4 – 30% reduction in
mortality from cervical cancer
VISION: A world without cervical cancer
GOAL: Reduce the incidence in countries
to reach < 4 cases 100 000 women-years
May 2018
World Health Assembly
adoption of strategy
Director-General Call to Action
Sept
2018
Global stakeholders forum
Jan
2019
Executive Board decision on the global strategy
April
2019
Online consultation
April‒Aug
2019
Regional consultations
(Eastern Mediterranean Region 1820
June)
Jan
2020
Executive Board
May
2020
Oct
2019
Regional Committee for the Eastern
Mediterranean 2019
19. Way forward
Regional cross-departmental task force established to
provide technical support to Member States
Need to strengthen cancer registries and data to inform
policy
Discuss at national level how best to integrate cervical
cancer interventions in overall national cancer control
programme
Introduction of HPV-vaccination in GAVI-eligible countries of
the Region
Review of nation cervical cancer “screen and treat” methods
– HPV-testing and optimal precancerous lesion treatment
modalities
Include cervical cancer screening, treatment and palliative
care services in national health benefits package
19
20. Tehran,
Islamic Republic of Iran
14 –17 October 2019
20
Agenda item 4(g)
Dr Rana Hajjeh,
Director, Programme
Management
Development of a proposal
for a Decade of Healthy
Ageing (2020-2030)
21. 69th World Health Assembly (WHA69.3)
21
To leverage the experience and lessons learned
from the implementation of the Global strategy and
action plan on ageing and health in order to better
develop a proposal for a Decade of Healthy Ageing
2020–2030 with Member States and with inputs
from partners, including United Nations agencies,
other international organizations, and
nongovernmental organizations
22. Decade of Healthy Ageing
22
The Decade of Healthy
Ageing is proposed as an
opportunity for global
collaboration led by WHO to
bring together governments,
international agencies,
health professionals,
academia, the media, the
private sector and civil
society to improve the lives
of older people, their
families and the
communities they live in.
23. Decade of Healthy Ageing
23
Globally, more than 1 billion
people are aged 60 or above,
most living in low- and middle-
income countries
Many do not have access to
the basic resources necessary
for a life of meaning and
dignity
The Decade looks to ensure
that all older people have an
equitable opportunity to be and
do the things that they value,
and that none are left behind
24. The Decade aims to stimulate
local action to ensure:
Communities develop in ways that foster the
abilities of older people;
Older people have access to quality health
care; and —
Older people, who need it, have access to
social care and support
24
(Guided by the Global strategy on ageing and health)
25. The Decade of Healthy Ageing will
be an opportunity to:
Nurture leadership at all
levels
Closely engage with older
people themselves
Work with governments to
frame policies that are
inclusive and supportive
of older people
25
26. Tehran,
Islamic Republic of Iran
14 –17 October 2019
26
Thirteenth General Programme of
Work (20192023) Results
Framework: an update
Agenda item 4(f)
Dr Arash Rashidian, Director,
Science, Information and
Dissemination
27. The GPW13 Results Framework is one of the
transformational shifts of WHO and aims to collectively
measure impact, track progress toward the health-related
SDGs and deliver on the triple billion targets
27
WHO transformational shift
28. Objectives
Update on the key advances on the development
of the GPW13 Results Framework
Invite valuable feedback from Member States on
next steps
Foster Member State ownership of and
commitment to the GPW13 Results Framework
Demonstrate the alignment of Vision 2023 to the
GPW13 Results Framework
28
29. 72nd World Health Assembly (WHA72.1)
Consultations on the WHO Impact Framework
prior to WHA72:
Online consultations and feedback
Geneva missions briefings
EB and WHA sessions
29
Requested the Director-General to continue
developing the results framework of GPW13
2019‒2023 in consultation with the Member
States and through Regional Committees
30. 30
GPW13 Results Framework
Strategic priorities |
Triple billion targets
Constitutional objective |
Healthy life expectancy
GPW13ImpactMeasurementProgrammeBudget
Country
case studies
Balanced
scorecard
Outputs
Countrycasestudies
Outcomes | Indicators and milestones
31. 31
Vision 2023
WHO impact framework
31
31
46 programmatic indicators and milestones
Healthy
life
expectancy
(HALE)
Triple billion targets
Universal
health coverage
Health
emergencies
Healthier
populations
3
2
1 Impact indicator HALE
– to be added to regional
“core” list from 2020
Corresponds with
Region’s 75 core
indicators
Better coverage of
emergency situations
40 of 46 already among
the core list; 43/46 among
regional priorities
32. Balanced scorecard
32
For each of the 42
outputs in the Results
Framework, 6
dimensions will be
assessed
1. Effective
delivery:
leadership
function
5. Delivering
value for
money
6.
Achievement
of results in
ways leading
to impacts
4. Impactful
integration of
gender, equity
and human rights
3. Effective
delivery:
Technical
support at the
country level
2. Effective
delivery:
global goods4
4
3
33
2
Output 1.1.1
Region has developed 56
KPIs to assess WHO’s
performance at regional
and national level
33. Country case studies
33
Achievements,
successful
interventions
and lessons
learned
2‒4 countries of
the Region to
be included in
the first year to
test the
approach and
plan for
expansion
34. Country contribution to the global
triple billion targets
34
Universal
health
coverage
index
Health
emergencies
index
Healthier
populations
index
Country case
study example
2023 population:
35.7 million
+ 9.0
million
+ 35.7
million
+ 14.3
million
2018 2023
Contribution
to global
billion
8.9
millio
n
17.9
million
Leve
l 1
Leve
l 2
Base-
line
14.3
million
Difference in
population covered
If moved up a level
= total population
Number of people
with healthier lives
35. Data and health information systems
35
Monitor global health
trends
Provide reliable and
actionable data to monitor
global, regional and
national health trends,
SDGs, GPW13 and health
inequalities
Strengthened
country data
information
systems for health
Support countries in
use of data, including
World Health Data
Collection Platform, to
drive policies, impact
and deliver the triple
billion targets
Strengthen and scale up research and innovations
Strengthen evidence base, prioritize WHO’s norms and
standards, and improve research capacity, and scale up
innovations in countries in alignment with GPW13 and country
priorities
As per proposed programme budget 2020‒2021 Outcome 4.1
1 2
3
37. Consultative process: Next steps
37
Consultation and input from Member States on
the Results Framework during regional
committees: AugustOctober 2019
01
Technical experts meeting to review WHO
impact measurement methodologies: October
2019
02
Establish baselines and milestones WHO
Impact Framework programmatic indicators:
OctoberNovember 2019
03
Informal Member State consultation on
GPW13 Results Framework to update on
progress and present draft: 4 November 2019
04
Report to Executive Board: February 2020
Present to World Health Assembly: May 2020
05
38. Data availability
38
One third of countries do not have recent primary or
underlying data for over half of the SDG indicators
Source: World Health Statistics 2019, WHO
AVAILABILITY OF RECENT PRIMARY OR UNDERLYING DATA TO INFORM
GLOBAL SDG MONITORINGa
39. Also please send any further queries or
comments to:
emrgohis@who.int
Feedback on
next steps?
39
Global Strategy for TB Research and Innovation will support efforts by governments and other partners to accelerate TB research and innovation, and to improve equitable access to the benefits of research, through four clear objectives and recommendations
For more information on what these objectives mean:
Create an enabling environment for TB research and innovation to increase the capacity for conducting and using research outcomes equitably in a sustained and effective manner, by strengthening public–private partnerships; streamlining and harmonizing regulatory processes for the review of research protocols and products; and integrating civil society’s expectations, needs, interests and values into the research and development (R&D) process.
Increase financial investments in TB research and innovation, by setting a target contribution for TB research funding; developing innovative and collaborative financing mechanisms to facilitate the timely development and diffusion of appropriate and affordable biomedical tools and technologies; and a target contribution for the conduct of the social, health system and operational/implementation research that is vital to support effective scale-up of innovative strategies and tools.
Promote and improve approaches to data sharing to advance scientific discovery; reduce duplication of effort; and facilitate the translation of evidence to national and global polices on TB prevention, diagnosis, treatment and care.
Promote equitable access to the benefits of research and innovation by strengthening global and national access initiatives for TB vaccines, medicines and diagnostics, and by providing appropriate governance structures that foster research and innovation as a shared responsibility that is needs driven, evidence based and guided by the core principles of affordability, effectiveness, efficiency and equity, with a view to enabling everyone to access essential quality TB health products and services without facing financial hardship.
The results framework has three parts:
The impact framework
The balanced scorecard; and
Country case studies
The WHO Impact Framework is a three layer measurement system that tracks impact through quantitative targets and indicators. The three levels are the healthy life expectancy, triple billion targets, and the outcomes programmatic indicators and milestones.
The Balanced Scorecard measures the Secretariat’s outputs, which can be aggregated into measurement of outcomes.
Country case studies provide qualitative cross-cutting and wholistic view of WHO’s impact/contributions at country level.
These three components will allow us to measure the impact at all levels of the organization with a focus on countries.
The WHO impact framework is a three-layer measurement system:
46 programmatic indicators and milestones cover a range of health topics and provide a set of measurement indicators that will be used to measure the outcomes in the programme budget (38 of which are identical to SDGs).
The triple billion targets are: 1 billion more people benefiting from universal health coverage, 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being. The goal will be to achieve the triple billion targets by 2023. Each of the triple billion targets will be measured using composite indices.
Healthy life expectancy (HALE) quantifies expected years of life in good health at a particular age and can be considered a summary measure of the overall health of populations. It is proposed to use HALE within GPW13 as an overarching and comparable measure of the impact of the triple billion targets.
In addition to the balanced scorecard and impact framework, important information from country case studies will provide a more holistic view of WHO’s overall impact.
The case studies will highlight achievements, successful interventions and lessons learned. Country experiences and case case studies will be aligned with the GPW13 outcomes and outputs.
Critically important are investments in data, health information systems and innovations.
These are critically important functions that will accelerate the attainment of the SDGs.
Reliable, timely data and actionable data to track progress and improve policies and programmes are important. This area of work need particular attention.
WHO commits to strengthen country capacity to improve:
Countries’ data and health information systems, to facilitate the use of such data and information in policy-making and to deliver impacts,
The monitoring of global trends, and
Bringing to scale operational research and innovations.
We all agree data is the lifeblood of public health. Accurate understanding of the burden of disease, risk factors and mortality is important. Often this is not the case.
For about one third of countries, there is no recent primary or underlying data for over half of the SDG indicators.
With 52% of deaths (29.4 million deaths) around the world unrecorded without a cause of death, many health policy decisions are made without adequate information. While there are reliable global numbers of leading causes of death, many individual countries lack the basic information they need to make informed decisions.
Also important is to have analytical capacity to set priorities and projections, inform policy decisions, target investments and track progress.
Investing a sustained capacity in data, research and innovation are important accelerators to have reliable and actionable data and health information to track health-related SDGs and the triple billion targets. What gets measured, gets accomplished.
There is an urgent need for improved data availability, analytics and forecasting for global health monitoring and national priorities setting and decision-making.
May we receive feedback on the proposed results framework, in general, and on the next steps in particular?